These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26752990)

  • 61. Development and Evaluation of Celecoxib Emulgel by Using Natural Oil.
    Rajput A; Gaur R; Kulshreshtha M; Jadaun SS; Kumari V
    Antiinflamm Antiallergy Agents Med Chem; 2024 Feb; ():. PubMed ID: 38409718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
    Kouchak M; Mahmoodzadeh M; Farrahi F
    AAPS PharmSciTech; 2019 Jun; 20(5):210. PubMed ID: 31161269
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design, formulation and evaluation of a mucoadhesive gel from Quercus brantii L. and coriandrum sativum L. as periodontal drug delivery.
    Aslani A; Ghannadi A; Najafi H
    Adv Biomed Res; 2013; 2():21. PubMed ID: 23977649
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantification of topically delivered 5-aminolevulinic acid by lontophoresis across ex vivo human stratum corneum.
    Boddé HE; Roemelé PE; Star WM
    Photochem Photobiol; 2002 Apr; 75(4):418-23. PubMed ID: 12003133
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preparation, characterization, and stability studies of piroxicam-loaded microemulsions in topical formulations.
    Abd-Allah FI; Dawaba HM; Ahmed AM
    Drug Discov Ther; 2010 Aug; 4(4):267-75. PubMed ID: 22491209
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder.
    Prasanthi D; Lakshmi PK
    Int Braz J Urol; 2013; 39(1):63-75; discussion 76. PubMed ID: 23489517
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin.
    Yener G; Gönüllü U; Uner M; Değim T; Araman A
    Pharmazie; 2003 May; 58(5):330-3. PubMed ID: 12779049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of penetration enhancers on gel formulation of Zidovudine: in vivo and ex vivo studies.
    Pokharkar V; Dhar S; Singh N
    PDA J Pharm Sci Technol; 2010; 64(4):337-47. PubMed ID: 21502034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design and Characterization of Atenolol Transdermal Therapeutic Systems: Enhancement of Permeability via Iontophoresis.
    Keerthi H; Panakanti PK; Yamsani MR
    PDA J Pharm Sci Technol; 2012; 66(4):318-32. PubMed ID: 22767881
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Limonene enhances the in vitro and in vivo permeation of trimetazidine across a membrane-controlled transdermal therapeutic system.
    Krishnaiah YS; Al-Saidan SM
    Curr Drug Deliv; 2008 Jan; 5(1):70-6. PubMed ID: 18220554
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
    Gratieri T; Kalia YN
    Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Passive and iontophoretic transdermal penetration of chlorpromazine.
    Alvarez-Figueroa MJ; González-Aramundiz JV
    Pharm Dev Technol; 2008; 13(4):271-5. PubMed ID: 18649217
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
    Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
    Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Iontophoretic transdermal delivery of haloperidol.
    Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
    Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparation and evaluation of celecoxib transdermal patches.
    Jayaprakash S; Halith SM; Firthouse PM; Yasmin ; Nagarajan M
    Pak J Pharm Sci; 2010 Jul; 23(3):279-83. PubMed ID: 20566440
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A transdermal delivery system for glipizide.
    Ammar HO; Salama HA; Ghorab M; El-Nahhas SA; Elmotasem H
    Curr Drug Deliv; 2006 Jul; 3(3):333-41. PubMed ID: 16848735
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Formulation and Evaluation of Cefixime Trihydrate Matrix Tablets Using HPMC, Sodium CMC, Ethyl Cellulose.
    Sirisolla J; Ramanamurthy KV
    Indian J Pharm Sci; 2015; 77(3):321-7. PubMed ID: 26180278
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro.
    Nugroho AK; Li G; Grossklaus A; Danhof M; Bouwstra JA
    J Control Release; 2004 Apr; 96(1):159-67. PubMed ID: 15063038
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeted local simultaneous iontophoresis of chemotherapeutics for topical therapy of head and neck cancers.
    Gratieri T; Kalia YN
    Int J Pharm; 2014 Jan; 460(1-2):24-7. PubMed ID: 24219856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box-Behnken statistical design.
    Salem HF; Kharshoum RM; Sayed OM; Abdel Hakim LF
    Drug Dev Ind Pharm; 2018 Nov; 44(11):1871-1884. PubMed ID: 30044654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.